Insider Transactions in Q1 2024 at Homology Medicines, Inc. (FIXX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2024
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
265
-3.21%
|
$6,360
$24.2 P/Share
|
|
Mar 25
2024
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
1,095
+11.72%
|
-
|
|
Mar 25
2024
|
Charles Michaud Jr |
SELL
Open market or private sale
|
Direct |
75
-7.49%
|
$1,800
$24.2 P/Share
|
|
Mar 25
2024
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
268
-9.36%
|
$6,432
$24.21 P/Share
|
|
Mar 25
2024
|
Charles Michaud Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
6,448
+26.32%
|
-
|
|
Mar 25
2024
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
23,530
+31.33%
|
-
|
|
Jan 09
2024
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
13,037
-9.19%
|
$0
$0.57 P/Share
|
|
Jan 03
2024
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
7,280
-20.61%
|
$0
$0.57 P/Share
|
|
Jan 03
2024
|
Charles Michaud Jr |
SELL
Open market or private sale
|
Direct |
1,708
-12.84%
|
$0
$0.57 P/Share
|
|
Jan 01
2024
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
33,420
+11.16%
|
-
|
|
Jan 01
2024
|
Charles Michaud Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
4,240
+10.31%
|
-
|
|
Jan 01
2024
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
18,610
+18.04%
|
-
|